Literature DB >> 7543898

Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinase.

A Pandey1, H Duan, V M Dixit.   

Abstract

The Eph family of receptor protein tyrosine kinases (RPTKs) is the largest family of RPTKs. The signal transduction pathways initiated by this family have only recently begun to be explored. Using a yeast two-hybrid screen to identify molecules that interact with the cytoplasmic domain of Eck, it was previously shown that activated Eck RPTK bound to and stimulated phosphatidylinositol 3-kinase (Pandey, A., Lazar, D.F., Saltiel, A. R., and Dixit, V.M. (1994) J. Biol. Chem. 269, 30154-30157). Also isolated from this same screen was a novel protein containing SH3 and SH2 adapter modules that had striking homology to those found in the Src family of non-receptor tyrosine kinases. However, unlike other Src family members, it lacked a catalytic tyrosine kinase domain. Hence, this protein was designated SLAP for Src-like adapter protein. Using glutathione S-transferase fusion Proteins, it was demonstrated that SLAP bound to activated Eck receptor tyrosine kinase. Therefore, SLAP is a novel candidate downstream signaling intermediate and the first member of the Src family that resembles an adapter molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543898     DOI: 10.1074/jbc.270.33.19201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling.

Authors:  J Tang; S Sawasdikosol; J H Chang; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner.

Authors:  C Gu; S Park
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

Authors:  Nicolas Prevost; Donna Woulfe; Takako Tanaka; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 4.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

5.  Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos.

Authors:  Eui Kyun Park; Neil Warner; Yong-Sik Bong; David Stapleton; Ryu Maeda; Tony Pawson; Ira O Daar
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

6.  Src-like adaptor protein (SLAP) regulates B cell receptor levels in a c-Cbl-dependent manner.

Authors:  Leonard L Dragone; Margaret D Myers; Carmen White; Shyam Gadwal; Tomasz Sosinowski; Hua Gu; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

Review 7.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

8.  Activation of EphA receptors mediates the recruitment of the adaptor protein Slap, contributing to the downregulation of N-methyl-D-aspartate receptors.

Authors:  Sophia Semerdjieva; Hayder H Abdul-Razak; Sharifah S Salim; Rafael J Yáñez-Muñoz; Philip E Chen; Victor Tarabykin; Pavlos Alifragis
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

Review 9.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

10.  Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Yoonha Hwang; Amy-Joan L Ham; Jin Chen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.